Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial
Ami E. Iskandrian(University of Alabama at Birmingham), Whedy Wang(Carolina Veterinary Specialists), Luiz Belardinelli(Acorda Therapeutics (United States)), Hsiao D. Lieu(NGM Biopharmaceuticals (United States)), John J. Mahmarian(Houston Methodist), Ann Olmsted(Carolina Veterinary Specialists), Manuel D. Cerqueira(Cleveland Clinic), S. Richard Underwood(Royal Brompton Hospital), Brent Blackburn(Carolina Veterinary Specialists), Robert C. Hendel, Timothy M. Bateman(University of Missouri–Kansas City), João V. Vítola(Universidade Federal do Paraná)
Cited by 345
Related Papers
Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes
|JAMA|2009|817
Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects
|Diabetes Care|2004|789
AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update
|Journal of the American College of Cardiology|2001|691
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update
|Circulation|2001|666
Prognostic value of gated myocardial perfusion SPECT
|Journal of Nuclear Cardiology|2004|662